Investment
Features
FeesSafety
Academy
More
Pluang+

Compare eBay Inc (EBAY) vs Eli Lilly And Co (LLY) Price & Performance

Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

eBay Inc vs Eli Lilly And Co — how do they compare? eBay Inc trades at $111.7 (market cap $47.88B), while Eli Lilly And Co trades at $1,166.65 (market cap $1.06T). The key difference: Eli Lilly And Co is far larger — about 22.1× eBay Inc's market cap, and eBay Inc pays the higher dividend (1.15%). Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Eli Lilly And Co for 93 Days on average.

EBAYLLY
Market Cap
$47.88B$1.06T
Volume
2,781,1982,297,239
Sector
Consumer CyclicalHealth
52-Week High
$118.96$1.28K
52-Week Low
$79.41$799.57
Typical Hold Time
134 Days93 Days
Enterprise Value
$51.71B$1.11T
Dividend Yield
1.15%0.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

eBay Inc

EBAY trades at $111.98, up 4.6% with bullish technical signals and strong earnings momentum after beating Q2 2026 estimates. The company maintains robust profitability with 72% gross margins and 47% ROE, while analyst consensus targets $117.68. Recent news highlights strategic focus on collectibles and live commerce growth, though GameStop's acquisition interest and executive selling warrant monitoring.

EBAY presents a balanced investment case with solid fundamentals and positive technicals, but faces competitive pressures from Amazon's multi-platform tools and potential acquisition uncertainty. The stock offers moderate upside to consensus targets with execution-dependent growth in key verticals.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,169.93, up 1.07% on the day, with a bullish technical signal and strong fundamental momentum. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 exceeding the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights promising pipeline updates in weight-loss and diabetes drugs, reinforcing growth prospects.

Outlook remains favorable given dominant market position and innovation pipeline, though high valuation multiples pose a risk. Analyst consensus is strongly bullish with a $1,340 price target. Key risks include competitive pressures and execution challenges in scaling production to meet demand for blockbuster therapies.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EBAY

No sentiment data available yet.

LLY
69% Buy31% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About eBay Inc

eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.

Read more on EBAY →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →